Cancer Genetics Program
Over the last two decades, advances in the field of cancer genetics have given patients and their healthcare providers the opportunity to determine increased predisposition to certain cancers. New genetic discoveries are influencing our understanding of cancer development, diagnosis, prognosis and treatment.
As part of our mission to provide comprehensive and quality cancer care, the Lipson Cancer Center provides individualized cancer risk assessment and genetic testing services to individuals and families who are at increased risk for cancer. Identifying these at-risk individuals and groups enables Lipson team members to perform personalized medical management interventions that foster early cancer detection and even prevention, and improved quality of life for patients and their families.
Research and practical application of cancer genetics at Lipson Cancer Center includes the following activities:
- Conducting comprehensive cancer-specific genetic evaluations, including three-generation pedigrees and complete reviews of family histories
- Comprehensive genetic risk assessments, including the probability that a patient may carry a heritable or germ-line mutation
- Performing psychosocial assessments and counseling regarding the risks, limitations, and benefits of genetic testing
- Providing education regarding suspected hereditary cancer syndromes, including cancer risks associated with gene mutations, basic genetic concepts, inheritance patterns and concepts of penetrance and variable expressivity.
- Obtaining informed patient consents, and discussing cost- and insurance-related issues as well as concerns related to discrimination or confidentiality
- Coordinating genetic testing through certified laboratories, and providing interdisciplinary collaborations with oncologists and other specialists
- Disclosing test results during a formal post-test counseling session, with an explanation of the significance and implications of genetic test results, medical management options, and family member relevance
- Outlining risk-reduction options, and offering referrals for high-risk patients to the appropriate clinical services
- Offering up-to-date information for screening, prevention, and treatment as well as cancer-related research opportunities
At the Lipson Cancer Center, our clinical teams devote their advanced expertise in cancer genetics to the identification, testing and counseling of at-risk patients. Our hereditary cancer risk assessment program is an important part of our commitment to providing world-class oncology services to our patients and community.